Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lucas Regis
Observed names:
L. Regis,
L. Regis Placido,
L. Regis Plácido,
L. Regis-Placido,
Lucas Regis Placido,
Lucas Regis Plácido,
Lucas Regis*,
Regis, Lucas
show all 8
Institutions:
Vall d'Hebron Institut de Recerca,
Vall d'Hebron Hospital Universitari
Observed institutions:
Universitat Autònoma de Barcelona,
Vall d'Hebron Institut de Recerca,
Vall d'Hebron Hospital Universitari
ORCID:
0000-0001-7121-1946
Observed ORCID:
0000-0001-7121-1946
OpenAlex ID:
A5055737222
The Barcelona Predictive Model of Clinically Significant Prostate Cancer
2022
·
Juan Morote
, Angel Borque-Fernando
, et al.
·
Cancers
·
43
PDF
Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review
2022
·
Marina Triquell
, Miriam Campistol
, et al.
·
Cancers
·
30
PDF
Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?
2018
·
Juan Morote
, Anna Celma
, et al.
·
European Urology Oncology
·
27
A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy
2021
·
Aina Salazar
, Lucas Regis
, et al.
·
European Urology Oncology
·
26
A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand
2022
·
Juan Morote
, Ángel Borque-Fernando
, et al.
·
Cancers
·
21
PDF
Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancer
2016
·
Jacques Planas
, Ana Celma
, et al.
·
Scandinavian Journal of Urology
·
21
Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
2015
·
M. Olivan
, M. Rigau
, et al.
·
BioMed Research International
·
21
PDF
Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy
2017
·
Juan Morote
, Inma Comas
, et al.
·
Clinical Genitourinary Cancer
·
19
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial
2024
·
Alonso Garcia-Ruiz
, Carlos Macarro
, et al.
·
European Urology
·
17
Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category
2022
·
Juan Morote
, Miriam Campistol
, et al.
·
European Urology Open Science
·
17
PDF
Variaciones de la prostatectomía radical para una recuperación de la continencia urinaria precoz: una revisión sistemática
2019
·
A. Salazar
, L. Regis
, et al.
·
Actas Urológicas Españolas
·
16
Valor de la proteína STAT3 como factor pronóstico en el carcinoma renal de célula clara. Revisión sistemática
2018
·
D. Lorente
, E. Trilla
, et al.
·
Actas Urológicas Españolas
·
16
The current recommendation for the management of isolated high‐grade prostatic intraepithelial neoplasia
2021
·
Juan Morote
, Iván Schwartzmann
, et al.
·
British Journal of Urology
·
15
PDF
La resonancia magnética preoperatoria predice la recuperación temprana de la continencia urinaria tras la prostatectomía radical robótica
2018
·
L. Regis
, A. Salazar
, et al.
·
Actas Urológicas Españolas
·
15
Multiparametric MRI for Staging of Prostate Cancer: A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical Prostatectomy
2022
·
Marina Triquell
, Lucas Regis
, et al.
·
Cancers
·
14
PDF
The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer
2022
·
Juan Morote
, Miriam Campistol
, et al.
·
The World Journal of Men s Health
·
14
PDF
Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result
2020
·
Juan Morote
, Anna Celma
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
14
Revisión sistemática de los factores pronósticos del carcinoma renal
2016
·
D. Lorente
, E. Trilla
, et al.
·
Actas Urológicas Españolas
·
14
Behavior of chemiluminescent assays to measure serum testosterone during androgen deprivation therapy
2016
·
Juan Morote
, Inma Comas
, et al.
·
International Journal of Urology
·
14
PDF
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging
2023
·
Juan Morote
, Hayley Pye
, et al.
·
British Journal of Urology
·
13
PDF
Proclarix, A New Biomarker for the Diagnosis of Clinically Significant Prostate Cancer: A Systematic Review
2022
·
Míriam Campistol
, Juan Morote
, et al.
·
Molecular Diagnosis & Therapy
·
13
Early continence after radical prostatectomy: A systematic review
2019
·
A. Salazar
, L. Regis
, et al.
·
Actas Urológicas Españolas (English Edition)
·
13
Preoperative magnetic resonance imaging in predicting early continence recovery after robotic radical prostatectomy
2019
·
L. Regis
, A. Salazar
, et al.
·
Actas Urológicas Españolas (English Edition)
·
12
Free Testosterone During Androgen Deprivation Therapy Predicts Castration‐Resistant Progression Better Than Total Testosterone
2016
·
Lucas Regis
, Jacques Planas
, et al.
·
The Prostate
·
12
Comportamiento de la testosterona total y libre en suero como predictores del riesgo de cáncer de próstata y de su agresividad
2015
·
L. Regis
, J. Planas
, et al.
·
Actas Urológicas Españolas
·
12
Show more works
View as search
Works count:
120
Citation count:
646
H-index:
14
I10-index:
29
Year
Topic
Type